Important notice

Government Authentication Service

You will soon be able to access our online services using the Government Authentication Service. Get started and create your account now. Please note that the option of logging in with clicSÉQUR will be maintained for a certain period.

Gouvernement du Québec
Régie de l’assurance maladie

Notice of alternative medication authorization, May 10, 2023

Legal publication
Updated on

 26 May 2023

This notice was published on May 26, 2023.

  • Prazosin hydrochloride, tablets and capsules, 1 mg replaces Teva-Prazosin, tablets, 1 mg
  • Prazosin hydrochloride, tablets and capsules, 2 mg replaces Teva-Prazosin, tablets, 2 mg
  • Prazosin hydrochloride, tablets and capsules, 5 mg replaces Teva-Prazosin, tablets, 5 mg
Download (.pdf)
 101.18 KB
Related topics